Conditions: Sexual Dysfunctions, Psychological
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 945
Healthy volunteers: no

Brief summary:
To establish efficacy of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in 6-month treatment, vs placebo for Hypoactive Sexual Desire Disorder in premenopausal European women.

To evaluate safety and tolerability of flibanserin in such patients.

Detailed description:

Arms:
arm 1: 50 mg qhs arm 2: 100 mg qhs arm 3: placebo qhs

Interventions: intervention 1: 50 mg qhs intervention 2: 100 mg intervention 3: placebo
Intervention descriptions: intervention 1: flibanserin 50 mg intervention 2: flibanserin 100mg intervention 3: placebo

Protocol document: